This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
July 30, 2020
Nordic Nanovector Announces EU Patent Granted Covering the Use of Alpha37
July 30, 2020
GenSight Biologics Reports Interim Financial Results for the First Half of 2020 and Provides Operational Update
July 28, 2020
Strongbridge Biopharma plc to Host Second Quarter 2020 Financial Results Conference Call on August 4, 2020
July 27, 2020
Vicore Pharma doses first COVID-19 patient in the ATTRACT study in India
July 27, 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
July 22, 2020
GenSight Biologics reports final REALITY natural history study results confirming poor spontaneous recovery for LHON patients with ND4 mutation
July 17, 2020
Aprea Therapeutics Announces Expansion of Clinical Trial Evaluating Eprenetapopt for the Front-Line Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
July 17, 2020
Orexo Interim Report Q2 2020
July 17, 2020
BONESUPPORT HOLDING AB (publ) – Publishes Q2 2020 Interim report
July 10, 2020
BONESUPPORT HOLDING AB (publ) – Interim Report Q2 2020 – invitation to conference call and webcast